Reports Q1 revenue $19.5M vs $17.6M last year. “We are excited to begin 2025 with our fifteenth consecutive quarter of record revenue, achieving $19.5 million in the first quarter, an 11% increase year-over-year. This impressive top-line performance, coupled with a 16% rise year-over-year in diluted EPS, highlights the sustained demand for our innovative products and our team’s dedication to operational excellence. We are also pleased to maintain our quarterly cash dividend at $0.17 per share, underscoring our commitment to delivering value to our shareholders. With our new manufacturing facility on track for completion in July 2025, we are well-positioned to support our planned growth and build upon the momentum of our strong first quarter performance,” said Roger Susi, President and Chief Executive Officer of Iradimed (IRMD) Corporation.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRMD:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue